missing translation for 'onlineSavingsMsg'
Learn More
Please login to your online account to display your discounted pricing

Gibco™ RPMI 1640 Medium DFS Item

Originally developed to culture human leukemic cells in suspension and as a monolayer

$16.21 - $409.00

Specifications

Requires: Supplementation


Products 6
Catalog Number Mfr. No. Quantity Price Quantity  
Catalog Number Mfr. No. Quantity Price Quantity  
11875101
View Documents
Gibco™
LS11875101
100mL Each for $16.21
 
11875093
View Documents
Gibco™
LS11875093
500mL Each for $45.09
 
11875085
View Documents
Gibco™
LS11875085
1000mL Each for $77.50
 
11875127
View Documents
Gibco™
LS11875127
20 x 100mL Each for $281.00
 
11875119
View Documents
Gibco™
LS11875119
10 x 500mL Each for $399.00
 
11875135
View Documents
Gibco™
LS11875135
6 x 1000mL Each for $409.00
 
Description

Description

Roswell Park Memorial Institute (RPMI) 1640 Medium is suitable for a variety of mammalian cells, including HeLa, Jurkat, MCF-7, PC12, PBMC, astrocytes, and carcinomas.

  • RPMI is modified as follows: with L-glutamine, phenol red; without HEPES
  • Unique from other media because it contains reducing agent glutathione and high concentrations of vitamins
  • Contains biotin, vitamin B12, and PABA, which are not found in Eagle's Minimal Essential Medium or Dulbecco's Modified Eagle Medium
  • Vitamins inositol and choline are present in high concentrations
  • Contains no proteins, lipids, or growth factors
  • Requires supplementation, commonly with 10% Fetal Bovine Serum (FBS)
  • Uses sodium bicarbonate buffer system (2.0g/L), and therefore requires a 5-10% CO2 environment to maintain physiological pH
  • Sustainable packaging

Cell Culture, Mammalian Cell Culture

Order Info

Shipping Condition: Room Temperature

Specifications

Specifications

0.0
icon-pdf.png

Not for human or animal therapeutic use. Uses other than the intended use may be a violation of local law. Customers using Gibco RPMI 1640 in a manufacturing process, who have a submission with the FDA, may request a letter of authorization from Life Technologies to reference their Type II Drug Master File (DMF). For in vitro diagnostic use.